Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Fidelity Healthy Future FAPHX
- NAV / 1-Day Return 12.64 / +0.32 %
- Total Assets 9.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.050%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment —
- Status Open
- TTM Yield 0.07%
- Turnover 68%
USD | NAV as of May 22, 2024 | 1-Day Return as of May 22, 2024, 4:41 AM GMT+0
Morningstar’s Analysis FAPHX
Will FAPHX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 44.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
NVIDIA Corp | 10.22 | 983,977 | Technology |
Procter & Gamble Co | 6.75 | 650,460 | Consumer Defensive |
Nestle SA | 4.97 | 478,444 | Consumer Defensive |
Thermo Fisher Scientific Inc | 4.48 | 431,839 | Healthcare |
Vertex Pharmaceuticals Inc | 3.49 | 336,498 | Healthcare |
Regeneron Pharmaceuticals Inc | 3.47 | 333,984 | Healthcare |
UnitedHealth Group Inc | 3.23 | 311,166 | Healthcare |
Uber Technologies Inc | 2.78 | 267,463 | Technology |
L'Oreal SA | 2.73 | 262,832 | Consumer Defensive |
Tesla Inc | 2.29 | 220,968 | Consumer Cyclical |